These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 35373286)

  • 41. Outcomes of Hemodynamic Support With Impella for Acute Myocardial Infarction Complicated by Cardiogenic Shock at a Rural Community Hospital Without On-Site Surgical Back-up.
    Wilkins CE; Herrera TL; Nagahiro MK; Weathers LB; Girotra SV; Sandhu F
    J Invasive Cardiol; 2019 Feb; 31(2):E23-E29. PubMed ID: 30700627
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of mechanical circulatory support with venoarterial extracorporeal membrane oxygenation or Impella for patients with cardiogenic shock: a propensity-matched analysis.
    Karatolios K; Chatzis G; Markus B; Luesebrink U; Ahrens H; Divchev D; Syntila S; Jerrentrup A; Schieffer B
    Clin Res Cardiol; 2021 Sep; 110(9):1404-1411. PubMed ID: 33185749
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Schrage B; Ibrahim K; Loehn T; Werner N; Sinning JM; Pappalardo F; Pieri M; Skurk C; Lauten A; Landmesser U; Westenfeld R; Horn P; Pauschinger M; Eckner D; Twerenbold R; Nordbeck P; Salinger T; Abel P; Empen K; Busch MC; Felix SB; Sieweke JT; Møller JE; Pareek N; Hill J; MacCarthy P; Bergmann MW; Henriques JPS; Möbius-Winkler S; Schulze PC; Ouarrak T; Zeymer U; Schneider S; Blankenberg S; Thiele H; Schäfer A; Westermann D
    Circulation; 2019 Mar; 139(10):1249-1258. PubMed ID: 30586755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early Impella Support in Postcardiac Arrest Cardiogenic Shock Complicating Acute Myocardial Infarction Improves Short- and Long-Term Survival.
    Chatzis G; Markus B; Luesebrink U; Ahrens H; Divchev D; Syntila S; Scheele N; Al Eryani H; Tousoulis D; Schieffer B; Karatolios K
    Crit Care Med; 2021 Jun; 49(6):943-955. PubMed ID: 33729726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcomes of Impella CP insertion during cardiac arrest: A single center experience.
    Kamran H; Batra S; Venesy DM; Patten RD; Waxman S; Pyne C; Shah SP
    Resuscitation; 2020 Feb; 147():53-56. PubMed ID: 31891791
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience.
    Ouweneel DM; de Brabander J; Karami M; Sjauw KD; Engström AE; Vis MM; Wykrzykowska JJ; Beijk MA; Koch KT; Baan J; de Winter RJ; Piek JJ; Lagrand WK; Cherpanath TG; Driessen AH; Cocchieri R; de Mol BA; Tijssen JG; Henriques JP
    Eur Heart J Acute Cardiovasc Care; 2019 Jun; 8(4):338-349. PubMed ID: 30403366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bedside insertion of impella percutaneous ventricular assist device in patients with cardiogenic shock.
    Pieri M; Pappalardo F
    Int J Cardiol; 2020 Oct; 316():26-30. PubMed ID: 32473286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Three-year experience of catheter-based micro-axial left ventricular assist device, Impella, in Japanese patients: the first interim analysis of Japan registry for percutaneous ventricular assist device (J-PVAD).
    Toda K; Ako J; Hirayama A; Kinugawa K; Kobayashi Y; Ono M; Nishimura T; Sato N; Shindo T; Takayama M; Yasukochi S; Shiose A; Sawa Y;
    J Artif Organs; 2023 Mar; 26(1):17-23. PubMed ID: 35467195
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.
    Seyfarth M; Sibbing D; Bauer I; Fröhlich G; Bott-Flügel L; Byrne R; Dirschinger J; Kastrati A; Schömig A
    J Am Coll Cardiol; 2008 Nov; 52(19):1584-8. PubMed ID: 19007597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiogenic shock in a young woman with SCAD: The importance of early access to VA-ECMO in the community.
    Ya'Qoub L; Alqarqaz M; Cowger J; Nemeh H; Basir MB; Alaswad K; Koenig G
    Cardiovasc Revasc Med; 2024 Feb; 59():81-83. PubMed ID: 37385894
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impella Support Versus Intra-Aortic Balloon Pump in Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Meta-Analysis.
    Moustafa A; Khan MS; Saad M; Siddiqui S; Eltahawy E
    Cardiovasc Revasc Med; 2022 Jan; 34():25-31. PubMed ID: 33549497
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanical circulatory support with the Impella 5.0 device for postcardiotomy cardiogenic shock: a three-center experience.
    Engström AE; Granfeldt H; Seybold-Epting W; Dahm M; Cocchieri R; Driessen AH; Sjauw KD; Vis MM; Baan J; Koch KT; De Jong M; Lagrand WK; Van Der Sloot JA; Tijssen JG; De Winter RJ; De Mol BA; Piek JJ; Henriques JP
    Minerva Cardioangiol; 2013 Oct; 61(5):539-46. PubMed ID: 24096248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impella 5.0 Support in INTERMACS II Cardiogenic Shock Patients Using Right and Left Axillary Artery Access.
    Schibilsky D; Lausberg H; Haller C; Lenglinger M; Woernle B; Haeberle H; Rosenberger P; Walker T; Schlensak C
    Artif Organs; 2015 Aug; 39(8):660-3. PubMed ID: 26147682
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impella 5.0 therapy as a bridge-to-decision option for patients on extracorporeal life support with unclear neurological outcomes.
    Bernhardt AM; Zipfel S; Reiter B; Hakmi S; Castro L; Söffker G; Kluge S; Lubos E; Rybczinski M; Grahn H; Schrage B; Becher PM; Barten MJ; Westermann D; Blankenberg S; Reichenspurner H
    Eur J Cardiothorac Surg; 2019 Dec; 56(6):1031-1036. PubMed ID: 31038672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of Impella 5.0 and extracorporeal left ventricular assist device in patients with cardiogenic shock.
    Kondo T; Morimoto R; Mutsuga M; Fujimoto K; Okumura T; Shibata N; Kazama S; Kimira Y; Oishi H; Kuwayama T; Hiraiwa H; Usui A; Murohara T
    Int J Artif Organs; 2021 Nov; 44(11):846-853. PubMed ID: 34488481
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Microaxial Blood Pump Catheter( Impella) for Cardiogenic Shock].
    Toda K
    Kyobu Geka; 2022 Sep; 75(10):813-818. PubMed ID: 36155575
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes of Renal Function in Cardiogenic Shock Patients With or Without Mechanical Circulatory Support.
    Upadhyaya VD; Alshami A; Patel I; Douedi S; Quinlan A; Thomas T; Prentice J; Calderon D; Asif A; Sen S; Mehra A; Hossain MA
    J Clin Med Res; 2021 May; 13(5):283-292. PubMed ID: 34104280
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of microaxillar mechanical left ventricular support on renal resistive index in patients with cardiogenic shock after myocardial infarction: a pilot trial to predict renal organ dysfunction in cardiogenic shock.
    Markus B; Patsalis N; Chatzis G; Luesebrink U; Ahrens H; Schieffer B; Karatolios K
    Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(2):158-163. PubMed ID: 31246097
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High flow from Impella 5.5 with partial veno-arterial extracorporeal membrane oxygenation support: Case series.
    Ohira S; Pan S; Levine A; Haidry SA; Aggawal-Gupta C; Lanier G; Gass A; De La Pena C; Goldberg JB; Spielvogel D; Kai M
    Artif Organs; 2022 Jun; 46(6):1198-1203. PubMed ID: 35106793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fast myocardial recovery ensured by the combined use of V-A ECMO and IMPELLA CP in cardiogenic shock related to a pheochromocytoma crisis.
    Montalto A; Nicolò F; Polizzi V; Comisso M; Musumeci F
    J Card Surg; 2020 Sep; 35(9):2367-2369. PubMed ID: 32720331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.